South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Publisher Name :
Date: 31-Jan-2013
No. of pages: 91

South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Summary

GlobalData’s new report, “South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others” provides key market data on the South and Central America Drug Delivery Devices market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include Argentina, Brazil and Mexico.
- Market size and company share data for Drug Delivery Devices market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Cipla Medpro (Pty) Ltd., Hospira, Inc. and Baxter International Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices in South and Central America 10
3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
3.2 Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Drug Delivery Devices, South and Central America, Company share (2010-2011) 18
4 Drug Delivery Devices In Argentina 20
4.1 Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 20
4.2 Drug Delivery Devices, Argentina, Distribution Share (2010-2011) 26
4.2.1 Central Venous Catheters, Argentina, Distribution Share (2010-2011) 26
4.2.2 Infusion Systems, Argentina, Distribution Share (2010-2011) 26
4.2.3 Metered Dose Inhaler Devices, Argentina, Distribution Share (2010-2011) 27
4.2.4 Needle Free Injections, Argentina, Distribution Share (2010-2011) 27
4.3 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28
4.3.1 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28
4.3.2 Central Venous Catheters, Argentina, Company Share (2010-2011) 30
4.3.3 Infusion Systems, Argentina, Company Share (2010-2011) 32
4.3.4 Metered Dose Inhaler Devices, Argentina, Company Share (2010-2011) 34
4.3.5 Needle Free Injections, Argentina, Company Share (2010-2011) 35
5 Drug Delivery Devices In Brazil 36
5.1 Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 36
5.2 Drug Delivery Devices, Brazil, Distribution Share (2010-2011) 42
5.2.1 Central Venous Catheters, Brazil, Distribution Share (2010-2011) 42
5.2.2 Infusion Systems, Brazil, Distribution Share (2010-2011) 42
5.2.3 Metered Dose Inhaler Devices, Brazil, Distribution Share (2010-2011) 43
5.2.4 Needle Free Injections, Brazil, Distribution Share (2010-2011) 43
5.3 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44
5.3.1 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44
5.3.2 Central Venous Catheters, Brazil, Company Share (2010-2011) 46
5.3.3 Infusion Systems, Brazil, Company Share (2010-2011) 48
5.3.4 Metered Dose Inhaler Devices, Brazil, Company Share (2010-2011) 50
5.3.5 Needle Free Injections, Brazil, Company Share (2010-2011) 51
6 Drug Delivery Devices in Mexico 52
6.1 Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 52
6.2 Drug Delivery Devices, Mexico, Distribution Share (2010-2011) 58
6.2.1 Central Venous Catheters, Mexico, Distribution Share (2010-2011) 58
6.2.2 Infusion Systems, Mexico, Distribution Share (2010-2011) 58
6.2.3 Metered Dose Inhaler Devices, Mexico, Distribution Share (2010-2011) 59
6.2.4 Needle Free Injections, Mexico, Distribution Share (2010-2011) 59
6.3 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60
6.3.1 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60
6.3.2 Central Venous Catheters, Mexico, Company Share (2010-2011) 62
6.3.3 Infusion Systems, Mexico, Company Share (2010-2011) 64
6.3.4 Metered Dose Inhaler Devices, Mexico, Company Share (2010-2011) 66
6.3.5 Needle Free Injections, Mexico, Company Share (2010-2011) 67
7 Overview of Key Companies in South and Central America Drug Delivery Devices Market 68
7.1 GlaxoSmithKline plc 68
7.1.1 Company Overview 68
7.1.2 Share in the South and Central America Drug Delivery Devices Market 68
7.2 Boehringer Ingelheim GmbH 69
7.2.1 Company Overview 69
7.2.2 Share in the South and Central America Drug Delivery Devices Market 69
7.3 AstraZeneca PLC 70
7.3.1 Company Overview 70
7.3.2 Share in the South and Central America Drug Delivery Devices Market 70
7.4 Baxter International Inc. 71
7.4.1 Company Overview 71
7.4.2 Share in the South and Central America Drug Delivery Devices Market 71
7.5 Hospira, Inc. 72
7.5.1 Company Overview 72
7.5.2 Share in the South and Central America Drug Delivery Devices Market 72
7.6 B. Braun Melsungen AG 73
7.6.1 Company Overview 73
7.6.2 Share in the South and Central America Drug Delivery Devices Market 73
7.7 Fresenius Kabi AG 74
7.7.1 Company Overview 74
7.8 Teleflex Incorporated 74
7.8.1 Company Overview 74
7.9 Terumo Corporation 74
7.9.1 Company Overview 74
7.10 Medtronic, Inc. 75
7.10.1 Company Overview 75
7.11 Smiths Medical 75
7.11.1 Company Overview 75
7.12 CareFusion Corporation 75
7.12.1 Company Overview 75
7.13 3M Health Care Ltd. 76
7.13.1 Company Overview 76
7.14 C. R. Bard, Inc. 76
7.14.1 Company Overview 76
7.15 Edwards Lifesciences Corporation 76
7.15.1 Company Overview 76
7.16 Consort Medical plc 77
7.16.1 Company Overview 77
7.17 Arcomed AG 77
7.17.1 Company Overview 77
7.18 Nipro Corporation 77
7.18.1 Company Overview 77
7.19 Universal Medical Technologies Inc. 78
7.19.1 Company Overview 78
7.20 Becton, Dickinson and Company 78
7.20.1 Company Overview 78
7.21 Cook Medical Incorporated 78
7.21.1 Company Overview 78
7.22 INJEX - Equidyne Systems 79
7.22.1 Company Overview 79
7.23 Samtronic 79
7.23.1 Company Overview 79
7.24 Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A 79
7.24.1 Company Overview 79
7.25 PharmaJet, Inc. 79
7.25.1 Company Overview 79
8 Drug Delivery Devices Market Pipeline Products 80
9 Financial Deals Landscape 85
9.1 Partnerships 85
9.1.1 Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 85
9.1.2 Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 86
10 Appendix 87
10.1 Definitions of Markets Covered in the Report 88
10.1.1 Drug Delivery Devices 88
10.2 Research Methodology 89
10.3 Secondary Research 89
10.4 Primary Research 89
10.5 Models 90
10.6 Forecasts 90
10.7 Expert Panels 90
10.8 GlobalData Consulting 91
10.9 Currency Conversion 91
10.10 Contact Us 91
10.11 Disclaimer 91

1.1 List of Tables
Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10
Table 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 12
Table 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, 2004-2018 13
Table 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15
Table 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17
Table 6: Drug Delivery Devices, South and Central America, Company share by Revenue ($m), USD Constant, 2010-2011 19
Table 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 21
Table 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23
Table 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25
Table 10: Central Venous Catheters, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 11: Infusion Systems, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 12: Metered Dose Inhaler Devices, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 13: Needle Free Injections, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 14: Drug Delivery Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 29
Table 15: Central Venous Catheters, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 31
Table 16: Infusion Systems, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 17: Metered Dose Inhaler Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 34
Table 18: Needle Free Injections, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 19: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 37
Table 20: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 39
Table 21: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 41
Table 22: Central Venous Catheters, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 23: Infusion Systems, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 24: Metered Dose Inhaler Devices, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 25: Needle Free Injections, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 26: Drug Delivery Devices, Brazil, Company Share, USD Constant, (2010-2011) 45
Table 27: Central Venous Catheters, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 47
Table 28: Infusion Systems, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 49
Table 29: Metered Dose Inhaler Devices, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 30: Needle Free Injections, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 51
Table 31: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 53
Table 32: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55
Table 33: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57
Table 34: Central Venous Catheters, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 58
Table 35: Infusion Systems, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 58
Table 36: Metered Dose Inhaler Devices, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 37: Needle Free Injections, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 38: Drug Delivery Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 61
Table 39: Central Venous Catheters, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 63
Table 40: Infusion Systems, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 65
Table 41: Metered Dose Inhaler Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 66
Table 42: Needle Free Injections, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 67
Table 43: Drug Delivery DevicesMarket Pipeline Products 80
Table 44: Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 85
Table 45: Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 86

1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
Figure 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, by Revenue ($m), USD Constant, 2004-2018 13
Figure 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 14
Figure 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16
Figure 6: Drug Delivery Devices, South and Central America, Company share (%), 2011 18
Figure 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 20
Figure 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 22
Figure 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 24
Figure 10: Drug Delivery Devices, Argentina, Company Share (%), 2011 28
Figure 11: Central Venous Catheters, Argentina, Company Share (%), 2011 30
Figure 12: Infusion Systems, Argentina, Company Share (%), 2011 32
Figure 13: Metered Dose Inhaler Devices, Argentina, Company Share (%), 2011 34
Figure 14: Needle Free Injections, Argentina, Company Share (%), 2011 35
Figure 15: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 36
Figure 16: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 38
Figure 17: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 40
Figure 18: Drug Delivery Devices, Brazil, Company Share (%), 2011 44
Figure 19: Central Venous Catheters, Brazil, Company Share (%), 2011 46
Figure 20: Infusion Systems, Brazil, Company Share (%), 2011 48
Figure 21: Metered Dose Inhaler Devices, Brazil, Company Share (%), 2011 50
Figure 22: Needle Free Injections, Brazil, Company Share (%), 2011 51
Figure 23: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 52
Figure 24: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54
Figure 25: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56
Figure 26: Drug Delivery Devices, Mexico, Company Share (%), 2011 60
Figure 27: Central Venous Catheters, Mexico, Company Share (%), 2011 62
Figure 28: Infusion Systems, Mexico, Company Share (%), 2011 64
Figure 29: Metered Dose Inhaler Devices, Mexico, Company Share (%), 2011 66
Figure 30: Needle Free Injections, Mexico, Company Share (%), 2011 67
Figure 31: GlaxoSmithKline plc, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 68
Figure 32: Boehringer Ingelheim GmbH, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 69
Figure 33: AstraZeneca PLC, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 70
Figure 34: Baxter International Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 71
Figure 35: Hospira, Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 72
Figure 36: B. Braun Melsungen AG, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 73
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • MediPoint: Drug-Eluting Balloons – EU Analysis and Market Forecasts
    Published: 30-Sep-2013        Price: US $4450 Onwards        Pages: 396
    GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts”. The report provides in-depth insight into the use of DEB in the European Union (EU) for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics. The DEB market in......
  • MediPoint: Drug-Eluting Balloons – Current and Fuutre Players
    Published: 30-Sep-2013        Price: US $3500 Onwards        Pages: 178
    GlobalData has released its medical device report, "MediPoint: Drug-Eluting Balloons Current and Fuutre Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing Drug-Eluting Balloons (DEB) Market. In the report, the adoption of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic......
  • MediPoint: Drug-Eluting Balloons – US Analysis and Market Forecasts
    Published: 30-Sep-2013        Price: US $4450 Onwards        Pages: 377
    GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons US Analysis and Market Forecasts". The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occl......
  • MediPoint: Drug-Eluting Balloons – APAC Analysis and Market Forecasts
    Published: 30-Sep-2013        Price: US $4450 Onwards        Pages: 385
    GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons APAC Analysis and Market Forecasts". The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in Asia-Pacific (APAC). The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chr......
  • MediPoint: Drug-Eluting Balloons – South American Analysis and Market Forecasts
    Published: 30-Sep-2013        Price: US $4450 Onwards        Pages: 362
    GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons South American Analysis and Market Forecasts". The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in South America (SA), specifically Brazil. The report provides in-depth insight into the use of DEB in SA for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal ar......
  • U.S. and European Markets for Nebulizers – 2013
    Published: 1-Sep-2013        Price: US $6995 Onwards        Pages: 69
    The U.S. and European Markets for Nebulizers includes stationary compressor/jet nebulizers, portable compressor/jet nebulizers, ultrasonic nebulizers and vibrating mesh nebulizers. In the U.S. portable compressor and vibrating mesh nebulizers will see appreciable upswings in market value due to increasing consumer awareness of the benefits of delivery systems using nebulization technology. The total European Nebulizer market will continue to experience growth in overall unit sales of nebul......
  • Global Pulmonary Drug Delivery Systems Market 2012-2016
    Published: 1-Jul-2013        Price: US $2000 Onwards        Pages: 48
    TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market. TechNa......
  • European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts to 2017
    Published: 24-Jun-2013        Price: US $4650 Onwards        Pages: 300
    The European drug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies, to innovative platforms that hold a huge potential for the effective delivery ......
  • Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Global Forecasts To 2017
    Published: 24-Apr-2013        Price: US $4650 Onwards        Pages: 316
    The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery; the market is forecast till 2017. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs. The glob......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs